Roche to acquire PathAI in deal worth up to $1.05 billion
Acquisition strengthens Roche’s AI-powered digital pathology and precision diagnostics capabilities
Acquisition strengthens Roche’s AI-powered digital pathology and precision diagnostics capabilities
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
From cancer research to diagnostic solutions
Subscribe To Our Newsletter & Stay Updated